Initial presentation of renal cell carcinoma as a vaginal mass with excessive bleeding.

diagnosis renal cell carcinoma treatment vaginal metastasis

Journal

Przeglad menopauzalny = Menopause review
ISSN: 1643-8876
Titre abrégé: Prz Menopauzalny
Pays: Poland
ID NLM: 101263235

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 09 04 2022
accepted: 09 07 2022
entrez: 27 1 2023
pubmed: 28 1 2023
medline: 28 1 2023
Statut: ppublish

Résumé

Renal cancer is the seventh most common cancer in men and the tenth most common cancer in women. Renal cell carcinoma accounts for 3% of all adult malignancies and 85% of all primary renal tumours. It metastasizes most often to the lungs, liver, bones, and brain and very rarely to the vagina. We present a case of a 60-year-old patient, in whom the renal cell carcinoma manifested for the first time as an intense bleeding, soft tumour formation with dimensions 4/6 cm originating in the vagina. Renal cell carcinoma metastasizes in about 30% of cases. Metastasizing can be lymphatic, hematogenous, transcoelomic, or by direct invasion. Most commonly it affects the lungs, bones, adrenal glands, liver, lymph nodes, and brain. Much less often, it metastasizes to the thyroid, orbit, nasal structures, vagina, gallbladder, pancreas, sublingual tissues, and soft tissues of distal extremities. Metastases can be synchronous and metachronous. The described cases in the literature of renal cell carcinoma manifested with vaginal metastases are isolated. We present an extremely rare case of renal cell carcinoma manifested by profuse genital bleeding from a vaginal metastasis. In such cases, especially if the vaginal lesion does not appear as the primary vaginal carcinoma, we must consider the possibility of metastasis from renal carcinoma.

Identifiants

pubmed: 36704765
doi: 10.5114/pm.2022.124020
pii: 49876
pmc: PMC9871993
doi:

Types de publication

Case Reports

Langues

eng

Pagination

285-288

Informations de copyright

Copyright © 2022 Termedia.

Déclaration de conflit d'intérêts

The authors report no conflict of interest.

Références

CEN Case Rep. 2020 May;9(2):138-140
pubmed: 31916227
Radiographics. 2013 Oct;33(6):1691-716
pubmed: 24108558
Pan Afr Med J. 2013;14:62
pubmed: 23565309
Gynecol Oncol. 2004 Mar;92(3):970-3
pubmed: 14984968
Chin Med J (Engl). 2013;126(9):1793
pubmed: 23652071
J Urol. 1979 Jan;121(1):95-7
pubmed: 759654
Ann Oncol. 2019 May 1;30(5):706-720
pubmed: 30788497
BMC Urol. 2018 Jan 30;18(1):4
pubmed: 29382325
BMC Gastroenterol. 2007 Jan 31;7:4
pubmed: 17266757
Oncol Lett. 2015 Apr;9(4):1897-1901
pubmed: 25789064
Case Rep Pathol. 2018 Jun 04;2018:2109279
pubmed: 29967708

Auteurs

Angel Yordanov (A)

Department of Gynaecological Oncology, Medical University Pleven, Pleven, Bulgaria.

Stoyan Kostov (S)

Department of Gynaecology, Medical University of Varna "Prof. Dr. Paraskev Stoyanov", Varna, Bulgaria.

Yavor Kornovski (Y)

Department of Obstetrics and Gynaecology, Medical University of Varna "Prof. Dr. Paraskev Stoyanov", Varna, Bulgaria.

Yonka Ivanova (Y)

Department of Obstetrics and Gynaecology, Medical University of Varna "Prof. Dr. Paraskev Stoyanov", Varna, Bulgaria.

Stanislav Slavchev (S)

Department of Obstetrics and Gynaecology, Medical University of Varna "Prof. Dr. Paraskev Stoyanov", Varna, Bulgaria.

Gancho Kostov (G)

Department of Special Surgery, University Hospital Kaspela, Plovdiv, Bulgaria.

Strahil Strashilov (S)

Department of Plastic Restorative, Reconstructive and Aesthetic Surgery, University Hospital "Dr. Georgi Stranski", Medical University Pleven, Pleven, Bulgaria.

Classifications MeSH